MYGN logo

Myriad Genetics (MYGN) Depreciation And Amortization

Annual D&A

$61.90 M
+$9.20 M+17.46%

December 1, 2023


Summary


Performance

MYGN Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

Quarterly D&A

$15.60 M
+$500.00 K+3.31%

September 1, 2024


Summary


Performance

MYGN Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM D&A

$61.50 M
+$1.50 M+2.50%

September 1, 2024


Summary


Performance

MYGN TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

MYGN Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+17.5%-0.6%+5.7%
3 y3 years+72.9%+13.9%+16.7%
5 y5 years-15.2%-14.3%-15.9%

MYGN Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1.4%+17.5%-19.6%+20.9%-2.1%+17.6%
5 y5-year-15.2%+72.9%-19.6%+20.9%-15.9%+24.2%
alltimeall time-15.2%+3768.8%-19.6%+543.9%-15.9%>+9999.0%

Myriad Genetics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$15.60 M(+3.3%)
$61.50 M(+2.5%)
Jun 2024
-
$15.10 M(-3.8%)
$60.00 M(+3.1%)
Mar 2024
-
$15.70 M(+4.0%)
$58.20 M(-6.0%)
Dec 2023
$61.90 M(+17.5%)
$15.10 M(+7.1%)
$61.90 M(+2.3%)
Sep 2023
-
$14.10 M(+6.0%)
$60.50 M(+1.7%)
Jun 2023
-
$13.30 M(-31.4%)
$59.50 M(+0.7%)
Mar 2023
-
$19.40 M(+41.6%)
$59.10 M(+12.1%)
Dec 2022
$52.70 M(-16.1%)
$13.70 M(+4.6%)
$52.70 M(+0.8%)
Sep 2022
-
$13.10 M(+1.6%)
$52.30 M(-2.1%)
Jun 2022
-
$12.90 M(-0.8%)
$53.40 M(-7.0%)
Mar 2022
-
$13.00 M(-2.3%)
$57.40 M(-8.6%)
Dec 2021
$62.80 M(+75.4%)
$13.30 M(-6.3%)
$62.80 M(+26.9%)
Sep 2021
-
$14.20 M(-16.0%)
$49.50 M(-6.6%)
Jun 2021
-
$16.90 M(-8.2%)
$53.00 M(-1.5%)
Mar 2021
-
$18.40 M(+4.0%)
$53.80 M(-24.8%)
Dec 2020
$35.80 M(-50.3%)
-
-
Sep 2020
-
$17.70 M(0.0%)
$71.50 M(-0.7%)
Jun 2020
$72.00 M(-1.4%)
$17.70 M(-1.1%)
$72.00 M(-1.0%)
Mar 2020
-
$17.90 M(-1.6%)
$72.70 M(-0.5%)
Dec 2019
-
$18.20 M(0.0%)
$73.10 M(+0.3%)
Sep 2019
-
$18.20 M(-1.1%)
$72.90 M(-0.1%)
Jun 2019
$73.00 M(+34.2%)
$18.40 M(+0.5%)
$73.00 M(+4.7%)
Mar 2019
-
$18.30 M(+1.7%)
$69.70 M(+8.2%)
Dec 2018
-
$18.00 M(-1.6%)
$64.40 M(+8.2%)
Sep 2018
-
$18.30 M(+21.2%)
$59.50 M(+9.4%)
Jun 2018
$54.40 M(+12.6%)
$15.10 M(+16.2%)
$54.40 M(+3.4%)
Mar 2018
-
$13.00 M(-0.8%)
$52.60 M(+0.2%)
Dec 2017
-
$13.10 M(-0.8%)
$52.50 M(+0.4%)
Sep 2017
-
$13.20 M(-0.8%)
$52.30 M(+8.3%)
Jun 2017
$48.30 M(+80.2%)
$13.30 M(+3.1%)
$48.30 M(+15.6%)
Mar 2017
-
$12.90 M(0.0%)
$41.80 M(+18.1%)
Dec 2016
-
$12.90 M(+40.2%)
$35.40 M(+21.2%)
Sep 2016
-
$9.20 M(+35.3%)
$29.20 M(+9.0%)
Jun 2016
$26.80 M(+7.2%)
$6.80 M(+4.6%)
$26.80 M(+0.8%)
Mar 2016
-
$6.50 M(-3.0%)
$26.60 M(+0.4%)
Dec 2015
-
$6.70 M(-1.5%)
$26.50 M(+2.7%)
Sep 2015
-
$6.80 M(+3.0%)
$25.80 M(+3.2%)
Jun 2015
$25.00 M(+81.2%)
$6.60 M(+3.1%)
$25.00 M(+4.6%)
Mar 2015
-
$6.40 M(+6.7%)
$23.91 M(+13.9%)
Dec 2014
-
$6.00 M(0.0%)
$20.99 M(+20.4%)
Sep 2014
-
$6.00 M(+8.9%)
$17.43 M(+26.3%)
Jun 2014
$13.80 M(+55.1%)
$5.51 M(+58.3%)
$13.80 M(+30.7%)
Mar 2014
-
$3.48 M(+42.7%)
$10.56 M(+14.0%)
Dec 2013
-
$2.44 M(+2.8%)
$9.26 M(+2.2%)
Sep 2013
-
$2.37 M(+4.7%)
$9.06 M(+1.8%)
Jun 2013
$8.90 M(-1.9%)
$2.27 M(+3.9%)
$8.90 M(-0.7%)
Mar 2013
-
$2.18 M(-2.9%)
$8.96 M(-1.4%)
Dec 2012
-
$2.24 M(+1.5%)
$9.09 M(-0.5%)
Sep 2012
-
$2.21 M(-5.0%)
$9.13 M(+0.7%)
Jun 2012
$9.07 M(+25.6%)
$2.33 M(+1.1%)
$9.07 M(+5.2%)
Mar 2012
-
$2.30 M(+0.5%)
$8.62 M(+6.2%)
Dec 2011
-
$2.29 M(+6.7%)
$8.12 M(+6.7%)
Sep 2011
-
$2.15 M(+14.3%)
$7.61 M(+5.4%)
Jun 2011
$7.22 M(+1.9%)
$1.88 M(+4.3%)
$7.22 M(-41.9%)
Mar 2011
-
$1.80 M(+0.9%)
$12.43 M(+74.7%)
Dec 2010
-
$1.78 M(+1.5%)
$7.11 M(+0.7%)
Sep 2010
-
$1.76 M(-75.2%)
$7.06 M(-0.3%)
DateAnnualQuarterlyTTM
Jun 2010
$7.08 M(-25.0%)
$7.08 M(-301.6%)
$7.08 M(+190.4%)
Mar 2010
-
-$3.51 M(-302.5%)
$2.44 M(-70.8%)
Dec 2009
-
$1.74 M(-2.5%)
$8.36 M(-6.8%)
Sep 2009
-
$1.78 M(-27.1%)
$8.97 M(-5.0%)
Jun 2009
$9.45 M(+7.6%)
$2.44 M(+1.3%)
$9.45 M(+1.9%)
Mar 2009
-
$2.41 M(+2.6%)
$9.27 M(+1.3%)
Dec 2008
-
$2.35 M(+4.0%)
$9.15 M(+2.0%)
Sep 2008
-
$2.26 M(-0.1%)
$8.97 M(+2.1%)
Jun 2008
$8.78 M(+16.4%)
$2.26 M(-1.2%)
$8.78 M(+2.9%)
Mar 2008
-
$2.29 M(+5.5%)
$8.53 M(+4.0%)
Dec 2007
-
$2.17 M(+4.8%)
$8.20 M(+4.4%)
Sep 2007
-
$2.07 M(+3.0%)
$7.86 M(+4.1%)
Jun 2007
$7.54 M(+10.1%)
$2.01 M(+2.7%)
$7.54 M(+2.8%)
Mar 2007
-
$1.96 M(+7.2%)
$7.34 M(+3.4%)
Dec 2006
-
$1.82 M(+3.8%)
$7.10 M(+1.9%)
Sep 2006
-
$1.76 M(-2.6%)
$6.97 M(+1.7%)
Jun 2006
$6.86 M(+12.5%)
$1.80 M(+5.1%)
$6.86 M(+3.9%)
Mar 2006
-
$1.72 M(+1.5%)
$6.60 M(+3.0%)
Dec 2005
-
$1.69 M(+2.9%)
$6.40 M(+2.5%)
Sep 2005
-
$1.64 M(+6.3%)
$6.25 M(+2.6%)
Jun 2005
$6.09 M(+5.7%)
$1.55 M(+1.5%)
$6.09 M(+1.4%)
Mar 2005
-
$1.52 M(-0.9%)
$6.00 M(+1.2%)
Dec 2004
-
$1.54 M(+3.4%)
$5.93 M(+1.7%)
Sep 2004
-
$1.49 M(+1.9%)
$5.83 M(+1.2%)
Jun 2004
$5.77 M(+9.3%)
$1.46 M(+0.4%)
$5.77 M(+2.7%)
Mar 2004
-
$1.45 M(+1.3%)
$5.61 M(+2.9%)
Dec 2003
-
$1.44 M(+1.1%)
$5.45 M(+1.0%)
Sep 2003
-
$1.42 M(+8.7%)
$5.40 M(+2.3%)
Jun 2003
$5.28 M(+17.3%)
$1.31 M(+0.9%)
$5.28 M(+1.6%)
Mar 2003
-
$1.29 M(-6.2%)
$5.19 M(+1.7%)
Dec 2002
-
$1.38 M(+6.4%)
$5.10 M(+7.5%)
Sep 2002
-
$1.30 M(+6.2%)
$4.75 M(+5.6%)
Jun 2002
$4.50 M(+20.6%)
$1.22 M(+1.0%)
$4.50 M(+5.3%)
Mar 2002
-
$1.21 M(+17.9%)
$4.27 M(+6.2%)
Dec 2001
-
$1.02 M(-1.7%)
$4.02 M(+3.2%)
Sep 2001
-
$1.04 M(+5.0%)
$3.89 M(+4.4%)
Jun 2001
$3.73 M(+13.5%)
$992.60 K(+3.5%)
$3.73 M(+2.4%)
Mar 2001
-
$959.00 K(+6.7%)
$3.64 M(+5.2%)
Dec 2000
-
$898.80 K(+2.4%)
$3.46 M(+6.1%)
Sep 2000
-
$878.10 K(-2.9%)
$3.26 M(-0.7%)
Jun 2000
$3.28 M(+2.6%)
$904.70 K(+16.0%)
$3.28 M(+6.6%)
Mar 2000
-
$780.00 K(+11.4%)
$3.08 M(+2.7%)
Dec 1999
-
$700.00 K(-22.2%)
$3.00 M(-9.1%)
Sep 1999
-
$900.00 K(+28.6%)
$3.30 M(+3.1%)
Jun 1999
$3.20 M(-3.0%)
$700.00 K(0.0%)
$3.20 M(-5.9%)
Mar 1999
-
$700.00 K(-30.0%)
$3.40 M(-2.9%)
Dec 1998
-
$1.00 M(+25.0%)
$3.50 M(+6.1%)
Sep 1998
-
$800.00 K(-11.1%)
$3.30 M(0.0%)
Jun 1998
$3.30 M(+32.0%)
$900.00 K(+12.5%)
$3.30 M(+6.5%)
Mar 1998
-
$800.00 K(0.0%)
$3.10 M(+3.3%)
Dec 1997
-
$800.00 K(0.0%)
$3.00 M(+7.1%)
Sep 1997
-
$800.00 K(+14.3%)
$2.80 M(+12.0%)
Jun 1997
$2.50 M(+56.3%)
$700.00 K(0.0%)
$2.50 M(+38.9%)
Mar 1997
-
$700.00 K(+16.7%)
$1.80 M(+63.6%)
Dec 1996
-
$600.00 K(+20.0%)
$1.10 M(+120.0%)
Sep 1996
-
$500.00 K
$500.00 K
Jun 1996
$1.60 M
-
-

FAQ

  • What is Myriad Genetics annual depreciation & amortization?
  • What is the all time high annual D&A for Myriad Genetics?
  • What is Myriad Genetics annual D&A year-on-year change?
  • What is Myriad Genetics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Myriad Genetics?
  • What is Myriad Genetics quarterly D&A year-on-year change?
  • What is Myriad Genetics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Myriad Genetics?
  • What is Myriad Genetics TTM D&A year-on-year change?

What is Myriad Genetics annual depreciation & amortization?

The current annual D&A of MYGN is $61.90 M

What is the all time high annual D&A for Myriad Genetics?

Myriad Genetics all-time high annual depreciation & amortization is $73.00 M

What is Myriad Genetics annual D&A year-on-year change?

Over the past year, MYGN annual depreciation & amortization has changed by +$9.20 M (+17.46%)

What is Myriad Genetics quarterly depreciation & amortization?

The current quarterly D&A of MYGN is $15.60 M

What is the all time high quarterly D&A for Myriad Genetics?

Myriad Genetics all-time high quarterly depreciation & amortization is $19.40 M

What is Myriad Genetics quarterly D&A year-on-year change?

Over the past year, MYGN quarterly depreciation & amortization has changed by -$100.00 K (-0.64%)

What is Myriad Genetics TTM depreciation & amortization?

The current TTM D&A of MYGN is $61.50 M

What is the all time high TTM D&A for Myriad Genetics?

Myriad Genetics all-time high TTM depreciation & amortization is $73.10 M

What is Myriad Genetics TTM D&A year-on-year change?

Over the past year, MYGN TTM depreciation & amortization has changed by +$3.30 M (+5.67%)